Início › Carcinoma urotelial (células de transição) › Califórnia

Ensaios clínicos de Carcinoma urotelial (células de transição) em Califórnia

33 estudos para Carcinoma urotelial (células de transição) estão buscando participantes em locais em Califórnia.

Cidades em Califórnia

Texto oficial do estudo (Inglês)

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06524544

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #59, Santa Barbara

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05176483

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
Ronald Reagan UCLA Medical Center, Los Angeles
e mais 3

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07090499

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Keck Medicine of USC Koreatown, Los Angeles
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
e mais 1

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07566156

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Providence St. Johns Health Center, Santa Monica

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05874921

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 1045), Orange
University of California San Francisco ( Site 1044), San Francisco

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05562830

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

UCLA Hematology/Oncology - Alhambra, Alhambra
UCLA Hematology/Oncology - Atascadero, Atascadero
UCLA Hematology/Oncology - Beverly Hills, Beverly Hills
e mais 39

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Duarte, Duarte
Providence Medical Foundation, Santa Rosa

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07277413

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
TRIO-US (Translational Research in Oncology-US), Los Angeles
UCLA Hematology/Oncology - Santa Monica, Los Angeles
e mais 4

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07218380

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC San Diego Moores Cancer Center, La Jolla
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06439836

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

Research Site, Los Angeles

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07815665

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Michael G Oefelein Clinical Trials, Bakersfield
UC Irvine Health. Chao Family Comprehensive Cancer Center, Orange

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06774131

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

University of Southern California, Los Angeles
Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
Cedars-Sanai Medical Center, Los Angeles
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT06582017

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Research Site, Los Angeles

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07129993

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Community Cancer Institute, Clovis
USC/Norris Comprehensive Cancer Center, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04895709

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Los Angeles Cancer Network, Los Angeles
Pih Health Hematology Medical Oncology, Whittier

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06330064

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

RecrutandoFase 1 inicial

Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT07628634

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

City of Hope, Duarte
Los Angeles Cancer Network, Glendale
California Research Institute, Los Angeles
e mais 3

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT04198766

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Kaiser Permanente Anaheim Kraemer Medical Offices, Anaheim
Foothill Cardioology, Arcadia
Kaiser Permanente Baldwin Park Medical Center, Baldwin Park
e mais 58

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, San Francisco

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT07720284

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Urology Associates of Central California, Fresno
Urology Group of Southern California, Los Angeles
Comprehensive Urology, Los Angeles

Recrutando

Idades de 18 a 88 · Todos os sexos · Atualizado em 2 de jul. de 2026 · NCT06394869

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

USC Norris Comprehensive Cancer Center, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de jul. de 2026 · NCT07169734

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

University of California, Davis, Sacramento

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT06101290

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

City of Hope, Duarte
COH Lennar, Irvine

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de jun. de 2026 · NCT07484022

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT06682728

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

University of Southern California, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de dez. de 2025 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
e mais 3

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

University of Southern California, Los Angeles
University of California, San Francisco, San Francisco

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2025 · NCT05107674

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Sarcoma Oncology Center, Santa Monica

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de abr. de 2025 · NCT06493552

A Multicenter Cancer Biospecimen Collection Study

Curebase, San Francisco

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 12 de mar. de 2025 · NCT04510129

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.